Core Viewpoint - Palo Alto Networks, Inc. (PANW) is currently trading at a high price-to-earnings (P/E) multiple, raising concerns about its valuation amid slowing growth trends [2][6][9]. Valuation and Comparisons - PANW's forward 12-month P/E ratio is 74.26X, which is higher than the Zacks Security industry's ratio of 73.32X, indicating that PANW stock is overvalued [2]. - The stock trades at a premium compared to industry peers such as Check Point Software (19.67X), Fortinet (30.76X), and Okta Inc. (23.66X) [3]. Recent Acquisitions - In January, Palo Alto Networks completed the acquisition of Chronosphere for $3.35 billion, which is approximately 21 times Chronosphere's annual recurring revenue (ARR) of around $160 million [7]. - The company is also in the process of acquiring CyberArk Software for about $25 billion, expected to close by the second half of fiscal 2026, raising investor concerns about the management of two large acquisitions simultaneously [8]. Growth Trends - PANW is experiencing a slowdown in revenue growth, with a current growth rate in the mid-teens, down from mid-20s in fiscal 2023 [11]. - The company forecasts full-year revenue growth for fiscal 2026 to be in the range of 14-15%, with the first quarter of fiscal 2026 showing a 16% year-over-year revenue increase [12]. - Next-Generation Security (NGS) ARR growth has also decelerated, with expectations for fiscal 2026 growth at 26-27%, down from 32% in fiscal 2025 and over 45% in fiscal 2024 [14]. Market Performance - PANW shares have declined 21.1% over the past three months, underperforming the Zacks Security industry's decline of 19.2% and its peers like Fortinet, Okta, and Check Point Software [15]. - The stock has dipped below its 50-day and 200-day moving averages, indicating a bearish trend [18]. Conclusion - Despite being a leader in cybersecurity with a strong long-term growth trajectory, the slowing revenue and NGS ARR growth rates suggest limited near-term upside for PANW stock, which carries a Zacks Rank 4 (Sell) [20].
PANW Trades at Premium Valuation: Buy, Sell or Hold the Stock?